Research
Florida Center For Allergy & Asthma Research is a dedicated and highly-experienced research facility with a proven track record of conducting Phase II–IV respiratory clinical trials. Our multidisciplinary team of board-certified allergists/immunologists and research coordinators is committed to participant safety, scientific integrity, and equitable access to research.
- Main Therapeutic Focus: Asthma, Allergic Rhinitis, and Urticaria
- Sponsor Relationship: active partnerships with leading biopharmaceutical sponsors
- Languages: English and Spanish
- Facilities: North Dade (Aventura) and South Dade (Kendall Sunset)
Research History
Our research site has been instrumental in bringing many landmark therapies to market, contributing to advances across asthma, allergic rhinitis, and urticaria since 1977. Our work has included a 2003 Biologic / Monoclonal Antibody Landmark Achievement and a 2025 first oral drug ever approved for Chronic Idiopathic Urticaria.
Florida Center For Allergy & Asthma Research specializes in performing clinical trials in adults, adolescents and children for the indications of:
We are currently conducting a variety of clinical research studies on several new and existing drugs for Asthma.
If you’re interested in participating in our breakthrough research studies, please complete this form.
Patient Eligibility: Specific eligibility requirements vary by study protocol. However, patients most likely to qualify typically share the following characteristics:
- Diagnosed with persistent asthma (mild, moderate, or severe, depending on study)
- Ages 12 and older (adult and pediatric studies available)
- On current controller therapy (ICS, ICS/LABA, and/or a third controller) with suboptimal control
- Documented history of asthma exacerbations or frequent rescue inhaler use
- Willing and able to attend scheduled study visits
Patients who qualify and enroll may receive the following benefits:
- Access to Investigational Therapies
- No-Cost Study-Related Care
- Compensation for time and travel
- Enhanced Monitoring
- Personalized Asthma Education
- Insurance-Neutral: Participation in a clinical research study does not replace a patient’s standard medical care. We coordinate directly with referring providers to ensure continuity of care throughout the study.
Our research centers are located next to our Aventura and Kendall/Sunset clinical offices.
Both facilities
- Perform Phase II, III and IV clinical trials;
- Have all of the emergency equipment needed for adverse events;
- are located in the proximity of a hospital (Baptist Hospital and Aventura Hospital);
- Provide ample space for monitors to work with phone, fax and copy machines readily available;
- Are conveniently located in densely populated areas with easy access to the main expressways and airports.
FAQs
A clinical research study is a medical study tailored to answer questions about the safety and effectiveness of potential new medications. A clinical study helps to understand how a new medicine works on people.
A good number of clinical trials are also conducted on medications already existing on the market in order to collect valuable information with regards to safety, optimal dosage and efficacy.
First and foremost, all the drugs that we are currently benefiting from have been approved solely as a result of successful clinical trials.
Secondly, during a clinical trial the patient will acquire a wealth of knowledge with regards to their asthma. We will share a lot of our findings with you and help you better understand the proper management of asthma and avoid stressful and scary trips to the ER.
We would like to help you with making that decision: please feel free to contact us (see details above).
Diplomate of the American Board of Allergy & Immunology
Diplomate of the American Board of Allergy & Immunology
Diplomate of the American Board of Allergy & Immunology
Jaime Landman, MD
Zevy Landman, MD
Ileana M. Rodicio, MD
